Literature DB >> 15949523

Obesity and prostate cancer screening in the USA.

K R Fontaine1, M Heo, D B Allison.   

Abstract

OBJECTIVE: To estimate the association between body mass index (BMI: kg/m2) and prostate-specific antigen (PSA) cancer screening in a nationally representative sample of US men aged 50 years and older using data from the 2001 Behavioral Risk Factor Surveillance Survey. RESPONDENTS: Men aged 50 years or older classified by BMI as healthy weight range (18.5-24.9), overweight (25-29.9), obese class I (30-34.9), obese class II (35-39.9), and obese class III (> or =40). OUTCOME MEASURES: Interval since most recent screening for PSA.
RESULTS: Adjusting for age, race, smoking, education, employment, income and health insurance status, we found that, compared with men in the healthy weight range, men in the overweight [odds ratio (OR)=1.13; 95% confidence interval (95% CI)=1.04-1.35], obese class I (OR=1.26; 95% CI=1.06-1.36) and obese class II (OR=1.14, 95% CI=1.02-1.26) categories were significantly more likely to have obtained a PSA test within the previous year. A similar pattern was observed when we examined other screening intervals (e.g. within past 2 years, within past 3 years, etc.).
CONCLUSIONS: Among men aged 50 years and older, overweight and obesity is associated with obtaining a PSA test.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15949523     DOI: 10.1016/j.puhe.2004.09.002

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  11 in total

Review 1.  Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer.

Authors:  A G Renehan; H-C Yeh; J A Johnson; S H Wild; E A M Gale; H Møller
Journal:  Diabetologia       Date:  2012-04-04       Impact factor: 10.122

2.  Prostate-specific antigen (PSA) screening rates and factors associated with screening in Eastern Canadian men: Findings from cross-sectional survey data.

Authors:  Devan Tchir; Marwa Farag; Michael Szafron
Journal:  Can Urol Assoc J       Date:  2020-07       Impact factor: 1.862

3.  Trends in prostate-specific antigen test use, 2000-2005.

Authors:  Louie E Ross; Yhenneko J Taylor; Daniel L Howard
Journal:  Public Health Rep       Date:  2011 Mar-Apr       Impact factor: 2.792

4.  Association between obesity and frequency of high-grade prostate cancer on biopsy in men: A single-center retrospective study.

Authors:  Raffaele Baio; Giorgio Napodano; Christian Caruana; Giovanni Molisso; Umberto Di Mauro; Olivier Intilla; Umberto Pane; Costantino D'Angelo; Antonella Bianca Francavilla; Claudio Guarnaccia; Francesca Pentimalli; Roberto Sanseverino
Journal:  Mol Clin Oncol       Date:  2022-06-20

5.  Obesity and future prostate cancer risk among men after an initial benign biopsy of the prostate.

Authors:  Andrew Rundle; Michelle Jankowski; Oleksandr N Kryvenko; Deliang Tang; Benjamin A Rybicki
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04-23       Impact factor: 4.254

6.  Body mass index and prostate cancer severity: do obese men harbor more aggressive disease on prostate biopsy?

Authors:  Karim Chamie; Stephanie Oberfoell; Lorna Kwan; Jessica Labo; John T Wei; Mark S Litwin
Journal:  Urology       Date:  2013-03-07       Impact factor: 2.649

Review 7.  The impact of obesity on prostate cancer.

Authors:  Joep G H van Roermund; J Alfred Witjes
Journal:  World J Urol       Date:  2007-05-30       Impact factor: 4.226

8.  Associations of body mass index, smoking, and alcohol consumption with prostate cancer mortality in the Asia Cohort Consortium.

Authors:  Jay H Fowke; Dale F McLerran; Prakash C Gupta; Jiang He; Xiao-Ou Shu; Kunnambath Ramadas; Shoichiro Tsugane; Manami Inoue; Akiko Tamakoshi; Woon-Puay Koh; Yoshikazu Nishino; Ichiro Tsuji; Kotaro Ozasa; Jian-Min Yuan; Hideo Tanaka; Yoon-Ok Ahn; Chien-Jen Chen; Yumi Sugawara; Keun-Young Yoo; Habibul Ahsan; Wen-Harn Pan; Mangesh Pednekar; Dongfeng Gu; Yong-Bing Xiang; Catherine Sauvaget; Norie Sawada; Renwei Wang; Masako Kakizaki; Yasutake Tomata; Waka Ohishi; Lesley M Butler; Isao Oze; Dong-Hyun Kim; San-Lin You; Sue K Park; Faruque Parvez; Shao-Yuan Chuang; Yu Chen; Jung Eun Lee; Eric Grant; Betsy Rolland; Mark Thornquist; Ziding Feng; Wei Zheng; Paolo Boffetta; Rashmi Sinha; Daehee Kang; John D Potter
Journal:  Am J Epidemiol       Date:  2015-08-04       Impact factor: 4.897

9.  Obesity and Cancer Screening according to Race and Gender.

Authors:  Heather Bittner Fagan; Richard Wender; Ronald E Myers; Nicholas Petrelli
Journal:  J Obes       Date:  2011-12-15

10.  Prostate-specific antigen testing in inner London general practices: are those at higher risk most likely to get tested?

Authors:  Paul Nderitu; Mieke Van Hemelrijck; Mark Ashworth; Rohini Mathur; Sally Hull; Alexandra Dudek; Simon Chowdhury
Journal:  BMJ Open       Date:  2016-07-12       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.